Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetylcysteine for early-onset preeclampsia
PACTR202603712049354Phase 2Not yet recruiting
- Sponsor
- University of Lagos
- Start
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in preeclampsia comparing N-acetylcysteine with Placebo (2 arms). Primary endpoints: Time to disease progression and Progression to preeclampsia with severe features. Planned start Mar 2026; status: not yet recruiting.
02
Drugs
acetylcysteine
03
Conditions
preeclampsia
Beyond the preview
Go deeper on PACTR202603712049354.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202603712049354.